Medscape37m
Platelet-Rich Plasma Considered Effective but Not Approved for Hair Loss
The substantial data supporting platelet-rich plasma (PRP) therapy and exosomes for androgenic alopecia have yet to convince ...
Incyte's and Syndax's Graft Disease Treatment Niktimvo Gets FDA Approval for Vial Sizes
Incyte and Syndax Pharmaceutical said the Food and Drug Administration approved their graft disease treatment Niktimvo antibody in nine milligram and 22 milligram vial sizes.
Medscape21h
Trials Aim to Show Benefit of Orthobiologic for Knee OA
Dr Tsun Sean Law details the ARISE trials and outlines other orthobiologic treatments currently available — but not yet ...
Newsom committed California to making its own insulin. It’s at least a year behind his schedule
Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is ...
pharmaphorum13h
ImmunoGen ELAHERE wins accelerated FDA approval for ovarian cancer
ImmunoGen, Inc. has announced that its platinum-resistant ovarian cancer drug ELAHERE (mirvetuximab soravtansine-gynx) has been granted FDA accelerated approval. This first FDA antibody-drug ...
precisionmedicineonline20h
Adaptimmune to File for Lete-Cel FDA Approval Following Cuts and Restructuring
The firm is aiming to break even on its cash flow by 2027 by narrowing its focus on its sarcoma treatments and pipeline candidates with greatest potential.